Skip to main content
Livermore
Livermore
ZHEN

First Turn Management, LLC

SEC CIK
0001993440
Latest filing
Aug 14, 2026

Holdings in Q1 2025

Holdings as of Mar 31, 2025, filed May 15, 2025. Long positions only; changes compare share counts with Q4 2024.

Institution overview
Positions
35
−1 vs. Q4 2024
Portfolio value
$496.1M
−$62.3M (−11.2%) vs. Q4 2024
Filed
May 15, 2025
SEC
Holdings of First Turn Management, LLC in Q1 2025
SecurityClassSharesValue% of portfolioShare changeActionHistory
SLNOSoleno Therapeutics IncCOM29,115$2.08M0.4%+29,115NewHistory
PRAXPraxis Precision Medicines, Inc.COM NEW71,775$2.72M0.5%+26,239+57.6%AddedHistory
HROWHarrow, Inc.COM188,829$5.02M1.0%−116,045−38.1%ReducedHistory
MLTXMoonLake ImmunotherapeuticsCLASS A ORD179,196$7.00M1.4%+179,196NewHistory
HQYHealthequity, Inc.COM83,966$7.42M1.5%−41,901−33.3%ReducedHistory
RDNTRadNet, Inc.COM157,615$7.84M1.6%+157,615NewHistory
BPMCBlueprint Medicines CorpCOM92,033$8.15M1.6%+24,890+37.1%AddedHistory
SPRYARS Pharmaceuticals, Inc.COM669,010$8.42M1.7%+75,719+12.8%AddedHistory
APGEApogee Therapeutics, Inc.COM229,675$8.58M1.7%−23,050−9.1%ReducedHistory
PCVXVaxcyte, Inc.COM276,905$10.5M2.1%00.0%UnchangedHistory
ELVNEnliven Therapeutics, Inc.COM535,092$10.5M2.1%00.0%UnchangedHistory
ISRGIntuitive Surgical IncCOM NEW22,109$10.9M2.2%−12,923−36.9%ReducedHistory
ADMAAdma Biologics, Inc.COM566,945$11.2M2.3%−117,285−17.1%ReducedHistory
ORICOric Pharmaceuticals, Inc.COM2,027,430$11.3M2.3%+576,393+39.7%AddedHistory
JANXJanux Therapeutics, Inc.COM430,163$11.6M2.3%+46,561+12.1%AddedHistory
RVMDRevolution Medicines, Inc.COM340,109$12.0M2.4%−63,806−15.8%ReducedHistory
PODDInsulet CorpStock49,350$13.0M2.6%+49,350NewHistory
EXASExact Sciences CorpCOM300,909$13.0M2.6%−8,981−2.9%ReducedHistory
GKOSGLAUKOS CorpCOM136,241$13.4M2.7%+40,144+41.8%AddedHistory
SWTXSpringWorks Therapeutics, Inc.COM304,076$13.4M2.7%+304,076NewHistory
GHGuardant Health, Inc.COM315,737$13.5M2.7%+315,737NewHistory
AXSMAxsome Therapeutics, Inc.COM118,179$13.8M2.8%−73,967−38.5%ReducedHistory
VERAVera Therapeutics, Inc.CL A623,612$15.0M3.0%+158,805+34.2%AddedHistory
TGTXTG Therapeutics, Inc.COM400,644$15.8M3.2%+400,644NewHistory
ASNDAscendis Pharma A/SSPONSORED ADR113,278$17.7M3.6%+25,474+29.0%AddedHistory
BSXBoston Scientific CorpStock178,156$18.0M3.6%+178,156NewHistory
MRUSMerus N.V.COM463,960$19.5M3.9%+178,801+62.7%AddedHistory
NTRANatera, Inc.COM139,942$19.8M4.0%+40,783+41.1%AddedHistory
MIRMMirum Pharmaceuticals, Inc.COM503,014$22.7M4.6%−3,894−0.8%ReducedHistory
BBIOBridgeBio Pharma, Inc.COM656,699$22.7M4.6%+204,409+45.2%AddedHistory
XENEXenon Pharmaceuticals Inc.COM683,451$22.9M4.6%−1,535−0.2%ReducedHistory
NUVLNuvalent, Inc.COM331,927$23.5M4.7%+22,406+7.2%AddedHistory
ARGXArgenx SESPONSORED ADR41,911$24.8M5.0%−1,167−2.7%ReducedHistory
VRNAVerona Pharma plcSPONSORED ADS435,385$27.6M5.6%−206,516−32.2%ReducedHistory
INSMINSMED IncCOM PAR $.01401,629$30.6M6.2%−45,351−10.1%ReducedHistory

Sold out since Q4 2024 (9)

Positions held at the end of Q4 2024 that are gone from this filing.

Positions of First Turn Management, LLC sold out since Q4 2024
SecurityClassShares in Q4 2024Value in Q4 2024% of portfolio in Q4 2024History
ITCIIntra-Cellular Therapies, Inc.COM294,414$24.6M4.4%History
CRNXCrinetics Pharmaceuticals, Inc.COM453,376$23.2M4.2%History
GERNGeron CorpCOM3,893,327$13.8M2.5%History
DAWNDay One Biopharmaceuticals, Inc.Stock947,878$12.0M2.2%History
ACLXArcellx, Inc.COMMON STOCK152,356$11.7M2.1%History
BHVNBiohaven Ltd.COM262,442$9.80M1.8%History
CRMDCorMedix Inc.COM1,021,421$8.27M1.5%History
BCAXBicara Therapeutics Inc.COM346,170$6.03M1.1%History
SNDXSyndax Pharmaceuticals IncCOM441,587$5.84M1.0%History